🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07612982
Starting soon Not applicable

Hybrid vs Fluoroscopy-Guided Interlaminar Epidural Injection in Lumbar Spinal Stenosis

NCT07612982 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07
Last updated
2026-05-29

Condition(s) studied

Lumbar Spinal Stenosis

Investigational drug(s) / intervention(s)

Ultrasound-guided lumbar interlaminar epidural steroid injection with fluoroscopic confirmationFluoroscopy-guided lumbar interlaminar epidural steroid injection

Ultrasound-guided lumbar interlaminar epidural steroid injection with fluoroscopic confirmation: Lumbar interlaminar epidural steroid injection using betamethasone (CALES) will be performed under ultrasound guidance, followed by fluoroscopic confirmation of needle position and contrast spread.

Fluoroscopy-guided lumbar interlaminar epidural steroid injection: Lumbar interlaminar epidural steroid injection using betamethasone (CALES) will be performed according to standard clinical practice under fluoroscopic guidance, with fluoroscopic confirmation of needle position and contrast spread.

Study summary

Lumbar spinal stenosis is a common degenerative condition that can cause chronic low back and leg pain, especially during walking or standing. Interlaminar epidural steroid injections are widely used to relieve pain and improve function in patients who do not respond adequately to conservative treatments.

These injections are usually performed under fluoroscopic guidance, which allows accurate needle placement but exposes patients and healthcare providers to ionizing radiation. Ultrasound guidance has emerged as an alternative technique that avoids radiation exposure; however, ultrasound alone may not always confirm correct epidural spread of the injected medication.

This prospective, randomized clinical trial aims to compare two commonly used imaging approaches for interlaminar epidural steroid injections in patients with lumbar spinal stenosis: fluoroscopy-guided injection and ultrasound-guided injection with fluoroscopic confirmation (hybrid technique). The study will evaluate patient satisfaction, radiation exposure, procedure time, technical success, pain relief, and functional outcomes.

The results of this study are expected to help identify the most effective and safe imaging guidance method for interlaminar epidural steroid injections in patients with lumbar spinal stenosis.

Eligibility

Sex
ALL
Min age
40 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 40 and 75 years * Diagnosis of lumbar spinal stenosis confirmed by clinical evaluation and magnetic resonance imaging (MRI) * Presence of neurogenic claudication symptoms for at least 3 months * Inadequate response to conservative treatment, including medication, physical therapy, or exercise * Numeric Rating Scale (NRS) pain score ≥ 4 at baseline * Ability to provide written informed consent Exclusion Criteria: * Previous lumbar spine surgery * Vertebral fracture, spinal malignancy, or history of significant lumbar trauma * Peripheral vascular claudication or clinically significant peripheral polyneuropathy * Epidural steroid injection within the past 6 months * Medical conditions severely limiting ambulation unrelated to lumbar spinal stenosis (e.g., severe cardiopulmonary disease or advanced hip/knee osteoarthritis) * Pregnancy or breastfeeding * Coagulation disorders or inability to safely discontinue anticoagulant or antiplatelet therapy according to guideline recommendations * Known allergy to local anesthetics, corticosteroids, or contrast agents * Active local or systemic infection * Body mass index (BMI) \> 30 kg/m²

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Marmara University Pendik Training and Research Hospital Istanbul Pendik

More Marmara University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07612982 on ClinicalTrials.gov ↗ ← All trials in Turkey